George Rosenkranz To Receive 2013 Biotechnology Heritage Award
The National Academy of Medicine of Mexico made Rosenkranz an honorary member in recognition of his dedication to scientific work and to training Mexican colleagues at Syntex. Rosenkranz is a member of the New York Academy of Sciences and the Board of Governors of both the University of Tel Aviv and the Weizmann Institute of Science in Rehovot, Israel. He has been honored with the Mexican National Prize in Pharmaceutical Sciences, the Leadership Award of the Mexican Health Federation, and Mexico's Eduardo Liceaga Award, along with the Winthrop-Sears Award of the Chemical Heritage Foundation and The Chemists' Club.
In addition to being a leader in science Rosenkranz is a world-class bridge player. He has authored fourteen books on contract bridge, several with Phillip Alder of the New York Times, and has won eleven North American Bridge Championships. In 2000 Rosenkranz was the recipient of the American Contract Bridge League's Blackwood Award, and he was inducted into the ACBL's Hall of Fame for his contributions as theorist, writer, and player.
About the Biotechnology Heritage Award
The Biotechnology Heritage Award is presented yearly by the Chemical Heritage Foundation (CHF) since 1999, at a special ceremony during the BIO Annual International Convention. The award honors individuals who have contributed significantly to the growth of biotechnology through discovery, innovation, commercialization, and/or public understanding. Recipients include Joshua Boger, Herbert Boyer, Ronald Cape, Nancy Chang, George Rathmann, William Rutter, Robert Swanson, and Henri Termeer. In 2013, the Life Sciences Foundation (LSF) joins us in the Award, and in honoring these individuals whose lives encourage emulation, and inspire achievement.CHF and LSF work closely together to treasure the past, educate the present, and inspire the future. As cosponsors of the Biotechnology Heritage Award, they share the mutual goals of educating the public, nourishing a sense of pride within the biotechnology community, and developing the record of the remarkable contributions the molecular sciences make to our lives.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts